Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy-Reference-Cited by-同舟云学术

Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy

Published:2020-07 Issue:7 Volume:19 Page:102568
ISSN:1568-9972
Container-title:Autoimmunity Reviews
language:en
Short-container-title:Autoimmunity Reviews

Author:

Toniati Paola,Piva Simone,Cattalini Marco,Garrafa Emirena,Regola Francesca,Castelli Francesco,Franceschini Franco,Airò Paolo,Bazzani Chiara,Beindorf Eva-Andrea,Berlendis Marialma,Bezzi Michela,Bossini Nicola,Castellano Maurizio,Cattaneo Sergio,Cavazzana Ilaria,Contessi Giovanni-Battista,Crippa Massimo,Delbarba Andrea,De Peri Elena,Faletti Angela,Filippini Matteo,Filippini Matteo,Frassi Micol,Gaggiotti Mario,Gorla Roberto,Lanspa Michael,Lorenzotti Silvia,Marino Rosa,Maroldi Roberto,Metra Marco,Matteelli Alberto,Modina Denise,Moioli Giovanni,Montani Giovanni,Muiesan Maria-Lorenza,Odolini Silvia,Peli Elena,Pesenti Silvia,Pezzoli Maria-Chiara,Pirola Ilenia,Pozzi Alessandro,Proto Alessandro,Rasulo Francesco-Antonio,Renisi Giulia,Ricci Chiara,Rizzoni Damiano,Romanelli Giuseppe,Rossi Mara,Salvetti Massimo,Scolari Francesco,Signorini Liana,Taglietti Marco,Tomasoni Gabriele,Tomasoni Lina-Rachele,Turla Fabio,Valsecchi Alberto,Zani Davide,Zuccalà Francesco,Zunica Fiammetta,Focà Emanuele,Andreoli Laura,Latronico Nicola

Funder

Central Laboratory at ASST Spedali Civili of Brescia

Department of Laboratory Diagnostics

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference24 articles.

1. Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy;Grasselli;JAMA,2020

2. Critical care utilization for the COVID-19 outbreak in Lombardy, Italy: early experience and forecast during an emergency response;Grasselli;JAMA - J Am Med Assoc,2020

3. COVID-19: consider cytokine storm syndromes and immunosuppression;Mehta;Lancet,2020

4. Interleukin-6 use in COVID-19 pneumonia related macrophage activation syndrome;McGonagle;Autoimmun Rev,2020

Cited by 653 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The effect of tocilizumab administration on inflammatory markers in COVID-19 patients;The Egyptian Journal of Bronchology;2024-08-17

2. Effect of Tocilizumab Treatment on Seroconversion in Hyperinflammation Secondary to Covid 19;Acta Medica Alanya;2024-04-30

3. COVID-19: Recent Insight in Genomic Feature, Pathogenesis, Immunological Biomarkers, Treatment Options and Clinical Updates on SARS-CoV-2;Current Genomics;2024-03

4. Effectiveness of Tocilizumab in the Treatment of a Recent Kidney Transplant Recipient With COVID-19;Cureus;2024-01-29

5. Signaling pathways and potential therapeutic targets in acute respiratory distress syndrome (ARDS);Respiratory Research;2024-01-13